These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7819543)

  • 21. In vivo microdialysis to determine the relative pharmacokinetics of drugs.
    Nakashima M; Zhao MF; Nakashima MN; Sakurai M; Sasaki H; Matsuyama K; Ichikawa M
    Biol Pharm Bull; 1996 Jul; 19(7):988-94. PubMed ID: 8839975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated striatal dopamine levels following administration of D-DOPA and its alpha-keto acid metabolite DHPPA: behavioral and physiological studies in vivo in the rat.
    Brannan T; Prikhojan A; Yahr MD
    Brain Res; 1996 Apr; 718(1-2):165-8. PubMed ID: 8773780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of single and multiple treatments with L-dihydroxyphenylalanine (L-DOPA) on dopamine receptor-G protein interactions and supersensitive immediate early gene responses in striata of rats after reserpine treatment or with unilateral nigrostriatal lesions.
    Khan SM; Smith TS; Bennett JP
    J Neurosci Res; 1999 Jan; 55(1):71-9. PubMed ID: 9890435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.
    Lacombe E; Carcenac C; Boulet S; Feuerstein C; Bertrand A; Poupard A; Savasta M
    Eur J Neurosci; 2007 Sep; 26(6):1670-80. PubMed ID: 17822436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
    Cenci MA; Lee CS; Björklund A
    Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
    Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
    Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
    Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
    J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA.
    Tomiyama M; Kimura T; Maeda T; Tanaka H; Kannari K; Baba M
    Synapse; 2004 Jun; 52(3):218-22. PubMed ID: 15065221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic L-dopa alters striatal NMDA receptors in rats with dopaminergic injury.
    O'Dell SJ; Marshall JF
    Neuroreport; 1996 Nov; 7(15-17):2457-61. PubMed ID: 8981403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-DOPA and psychosis: evidence for L-DOPA-induced increases in prefrontal cortex dopamine and in serum corticosterone.
    Carey RJ; Pinheiro-Carrera M; Dai H; Tomaz C; Huston JP
    Biol Psychiatry; 1995 Nov; 38(10):669-76. PubMed ID: 8555378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized mice.
    Cooper DR; Marrel C; van de Waterbeemd H; Testa B; Jenner P; Marsden CD
    J Pharm Pharmacol; 1987 Oct; 39(10):809-18. PubMed ID: 2891818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
    Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMPA receptor blockade potentiates the stimulatory effect of L-DOPA on dopamine release in dopamine-deficient corticostriatal slice preparation.
    Juranyi Z; Sziray N; Marko B; Levay G; Harsing LG
    Crit Rev Neurobiol; 2004; 16(1-2):129-39. PubMed ID: 15581408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats.
    Morelli M; Pinna A; Fenu S; Carta A; Cozzolino A; Di Chiara G
    Synapse; 1994 Dec; 18(4):288-93. PubMed ID: 7886620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study.
    Boulamery A; Simon N; Vidal J; Bruguerolle B
    Chronobiol Int; 2010 Jan; 27(2):251-64. PubMed ID: 20370468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-dopa and L-dopa similarly elevate brain dopamine and produce turning behavior in rats.
    Karoum F; Freed WJ; Chuang LW; Cannon-Spoor E; Wyatt RJ; Costa E
    Brain Res; 1988 Feb; 440(1):190-4. PubMed ID: 3129126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR; Abercrombie ED
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE; Thomas LI
    Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.